ClinicalTrials.gg
RecruitingNCT07167927Updated Aug 10, 2026

Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis

An interventional study of Decision support tool in Children With Medical Complexity (CMC), Multiple Chronic Conditions and Neuromuscular Scoliosis, sponsored by University of Utah. Recruiting at 2 sites in United States. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by University of Utah · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Non-randomized
Ages
8 Years and older
Sex
All
01

Study summary

The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use during surgical treatment decision making for neuromuscular scoliosis (NMS). Results from this pilot will inform the design of a future larger effectiveness trial of the decision support tool.

Participants will either receive usual care or receive the decision support tool. Researchers will assess the decision made, decision quality, individual affective, cognitive, and behavioral effects, and feasibility and acceptability of tool use. They will also collect potential barriers and facilitators to implementation and feedback about the tool and study design to maximize likelihood of successful deployment of the tool into clinical practice and inform the design of a future trial. The outcomes measures will be used to inform potential effect size estimates to inform a future trial.

Read the detailed description

Neuromuscular scoliosis (NMS) can result in severe disability for children. Non-operative management including bracing and physical therapy minimally slows scoliosis progression, but operative management with posterior spinal fusion (PSF) carries high risks of morbidity and mortality in part due to the multiple comorbid conditions seen in children with NMS. Decisions like PSF that have no clear best treatment option are best served by shared decision making (SDM). SDM is a collaborative process where patients, parents, and providers share their knowledge, preferences, and values to reach treatment plan agreement. Our prior qualitative study creating a framework of SDM for children with multiple comorbid conditions like children with NMS found that parents face immense decision related uncertainty that often goes unacknowledged by providers and that parents and providers struggle with identifying and communicating family preferences and values that are important for treatment decision making. Our prior work has identified optimal methods to communicate uncertainty and identified the preferences and values parents of children with NMS have when it comes to treatment decision making for NMS. This study will pilot test a decision support tool that contains these elements.

02

Conditions studied

  • Children With Medical Complexity (CMC)
  • Multiple Chronic Conditions
  • Neuromuscular Scoliosis
  • Shared Decision Making
  • Decision Support Systems, Clinical
  • Decision Aids

Keywords

  • children with medical complexity
  • shared decision making
  • values clarification
  • uncertainty communication
  • decision support tool
03

In context

Multiple Chronic Conditions

89 studies on the registry are indexed under Multiple Chronic Conditions; 16 are open to participants now.

This study's planned enrollment of 110 is below the median of 128 across 71 interventional studies indexed under Multiple Chronic Conditions.

Browse Multiple Chronic Conditions studies →

Lead sponsor

University of Utah is the lead sponsor of 994 studies on the registry; 175 are open to participants now.

Of its 114 completed or terminated interventional studies of FDA-regulated products, 69 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parent-child dyads of children with neuromuscular scoliosis who speak English and Spanish.
  • Child is between ages 8-21 years of age and they are coming into the pediatric orthopaedic surgery clinic for consultation about potential surgery for NMS.
  • NMS is defined as having neurologic impairment (NI) and scoliosis using relevant ICD-9 or ICD-10 codes from Feudtner, et al. 2014 or Berry, et al. 2012. or a qualifying diagnosis per the Pediatric Spine Study Group definition of NMS.
  • All pediatric orthopaedic surgeons and neurosurgeons who treat neuromuscular scoliosis at our study sites will be eligible participants.

Exclusion criteria

Exclusion criteria:

  • Families whose child with NMS is less than 8 years of age at time of orthopaedic consultation because surgery at a younger age usually indicates an atypical case.
  • Children with the diagnosis of Becker's muscular dystrophy due to potential disease modifying therapies that may alter curve progression.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
110 participants (estimated)

Study arms

  • No intervention
    Usual care

    Participants receive usual care

  • Experimental
    Decision support tool

    Participants receive the novel decision support tool

    Behavioral: Decision support tool

Interventions

  • BehavioralDecision support tool

    Decision support tool developed for patients, parents, and providers of children with neuromuscular scoliosis

06

What researchers measure

Primary outcomes

  1. Intention for NMS treatment

    Parent degree of decision preference (1: no surgery-9: surgery)

    Time frame: Immediately after clinic visit

Secondary outcomes

  1. Intention for NMS treatment

    Parent's desired treatment option: Binary (1- surgery, 0- no surgery)

    Time frame: Immediately after clinic visit

  2. Intention for not delaying treatment

    For parents who select surgery, the intention of treatment timing.

    Time frame: Immediately after clinic visit

  3. Knowledge questions

    Parent's response to five decision-related knowledge questions, scored as total answered correctly

    Time frame: Immediately after clinic visit

  4. Acceptability of intervention

    Measured quantitatively by the validated Acceptability of Intervention Measure for caregivers in the intervention group. The scale consists of 4 items rated on a 5-point Likert scale. A mean score is created with a higher score indicating higher acceptability.

    Time frame: Immediately after clinic visit

  5. Physician trustworthiness

    The Dugan Physician Trust Scale is a validated 5-item survey measure to assess the participant's trust in their physician. Each item is rated on a 5-point Likert scale and one item is reverse coded before all items are summed to create a composite score. Higher scores indicate stronger trust in the physician.

    Time frame: Immediately after clinic visit

  6. Feasibility of intervention

    Measured by the validated Feasibility of Intervention Measure. The scale consists of 4 items rated on a 5-point Likert scale. A mean score is created with a higher score indicating higher acceptability.

    Time frame: Immediately after clinic visit

  7. Risk perception

    2 unique items on perception of risk related to decision, scored individually. Each item is rated on a 5-point Likert scale. The items will be scored individually with higher responses indicating higher perceived decision-related risk.

    Time frame: Immediately after clinic visit

  8. Decision conflict

    Decisional conflict scale and 2 unique decision conflict items (individual items scored individually). Each item is rated on a 5-point Likert scale. The items will be scored individually with higher responses indicating higher decisional conflict.

    Time frame: Immediately after clinic visit

  9. Decision readiness

    Preparation for Decision Making (PrepDM): The PrepDM scale is a validated 10-item survey measure that evaluates the participant's perception of how helpful their clinic visit was in preparing them to make the decision. Each item is rated on a 5-point Likert scale, and scores are standardized to a 0-100 scale, with higher scores indicating greater perceived readiness for decision-making.

    Time frame: Immediately after clinic visit

  10. Acceptability of Intervention- Qualitative

    Qualitatively assessed via focus groups and individual interviews for caregivers in intervention group and provider participants.

    Time frame: Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).

  11. Worry

    Consists of 3 unique items to assess the participant's level of worry related to decision making. Each item is rated on a 5-point Likert scale. The items will be scored individually with higher responses indicating higher levels of decision-related worry.

    Time frame: Immediately after clinic visit

  12. Quality of shared decision making

    Quantitatively via the 9-item SDM-Q-9 (parent) and SDM-Q-Doc (provider) surveys. Each item is rated on a 6-point Likert scale. The total score is standardized to a scale from 0 to 100, with higher scores indicating greater perceived involvement in decision-making.

    Time frame: Immediately after clinic visit

  13. Decisional self-efficacy

    The Decisional Self-Efficacy Scale is a validated 11-item survey measure that evaluates the participant's ability to make informed health-related decisions. Items are rated on a 5-point Likert scale and scores are standardized to a 0-100 scale, with higher scores reflecting greater decisional self-efficacy.

    Time frame: Immediately after clinic visit

  14. preference concordance for parents

    Compare parent self-rated top three values/preferences driving decision making with decision they chose for consistency of decision with values/preferences. Will be scored based on number of values (out of 3) that match the treatment option selected.

    Time frame: Immediately after clinic visit

  15. Appropriateness of intervention

    Measured quantitatively by the validated Appropriateness of Intervention Measure. The scale consists of 4 items rated on a 5-point Likert scale. A mean score is created with a higher score indicating higher acceptability.

    Time frame: Immediately after clinic visit

  16. Preference concordance between parents and providers

    Correlation between top three parent preferences and values for decision identified by parents and by providers, calculated via a kappa score.

    Time frame: Immediately after clinic visit

  17. Feasibility of Intervention- Qualitative

    Qualitatively assessed via focus groups and individual interviews for caregivers in intervention group and provider participants.

    Time frame: Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).

  18. Appropriateness of Intervention- Qualitative

    Qualitatively assessed via focus groups and individual interviews for caregivers in intervention group and provider participants.

    Time frame: Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).

  19. Quality of shared decision making- qualitative

    Using the DEEP-SDM coding scheme on video- and audio-recorded clinical encounters

    Time frame: During clinic visit

Other outcomes

  1. Barriers and facilitators to implementation

    Qualitative analysis of interviews and focus groups from intervention group participants using the CFIR

    Time frame: Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).

  2. Quality of interpretation

    5-item survey questions based on Napoles 2015 and qualitative analysis of recorded clinic visits to assess quality of interpretation. The first item assesses the type and need for interpretation, with participants selecting from 7 categories. If an interpreter was used, participants will then answer 4 additional items about the quality of interpretation for the visit. Each of these subsequent items is rated on a 5-point Likert scale (1-poor to 5-excellent). A mean composite outcome of the completed items is used to calculate overall quality.

    Time frame: immediately after clinic visit

  3. Usability of intervention

    System Usability Scale (SUS): The SUS is a validated 10-item survey measure that evaluates the perceived usability of the intervention. Items are rated on a 5-point Likert scale and scores are calculated by converting responses to a 0-100 scale, with higher scores indicating better usability. Only parent participants assigned to the intervention group will answer this measure.

    Time frame: Immediately after clinic visit

  4. Mental load of intervention

    NASA Task Load Index (NASA-TLX): The NASA-TLX is a validated measure used to assess the perceived mental workload of using the intervention. It consists of 6-items to measure 6 core dimensions: mental demand, physical demand, temporal demand, performance, effort, and frustration. Each dimension is rated on a scale from 0 to 100, and scores are combined to produce an overall workload score. Higher scores indicate greater perceived workload. Only parent participants assigned to the intervention group will answer this measure.

    Time frame: Immediately after clinic visit

  5. Tool use

    Metadata on tool interaction, inputs, and use

    Time frame: End of study, approximately 18 months after first enrollment.

  6. Severe pneumonia

    Chart review of medical records to count number of admissions for pneumonia.

    Time frame: Within 18 months of clinic visit

  7. Readability

    Consists of 2 unique items to assess how clearly the intervention is presented. Each item is rated on a 5-point Likert scale. The items will be scored individually. Only parent participants assigned to the intervention group will answer these items.

    Time frame: Immediately after the clinic visit

  8. provider preferences and values for decision making

    provider free response of top three reasons for decisiion that was made

    Time frame: immediately after clinic visit

  9. parent preferences and values

    selection of top three parent preferences and values for decision making from a list of options including a free response "other" field; asked to parent/patient participants and provider participants

    Time frame: immediately after visit

  10. Quality of interpretation

    Qualitative analysis of quality of interpretation captured on video-recordings of clinic visits.

    Time frame: During clinic visit

  11. Decision adherence

    Chart review of medical records to assess adherence to decision made.

    Time frame: Within 18 months after clinic visit.

  12. Pain symptoms

    Chart review of patient record for changes in pain symptoms related to scoliosis. Options include: worsened, unchanged, improved, not mentioned.

    Time frame: Within 18 months of clinic visit

  13. Surgical outcomes

    Chart review of medical records to assess for presence surgical outcomes: minor complications, major complications.

    Time frame: Within 18 months of clinic visit

  14. Sitting comfort

    Chart review of patient record for changes in sitting comfort symptoms related to scoliosis. Options include: worsened, unchanged, improved, not mentioned.

    Time frame: Within 18 months of clinic visit

  15. ICU length of stay

    For those who undergo surgery, the days the patient spent in the ICU after surgery

    Time frame: Within 18 months of clinic visit

  16. Total length of stay

    For those who undergo surgery, the days the patient spent in the the hospital after surgery

    Time frame: Within 18 months of clinic visit

  17. Length of ventilation

    For those who undergo surgery, the days the patient spent on mechanical ventilation (if not ventilated at baseline) or days spent on higher than normal mechanical ventilation settings (if ventilated at baseline).

    Time frame: Within 18 months of clinic visit

  18. Pneumonia hospital days

    Chart review of medical records to count number of days admitted for pneumonia.

    Time frame: Within 18 months of clinic visit

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07167927
Lead sponsor
University of Utah
Responsible party
Jody Lin (MD, University of Utah) — Principal investigator
First posted
Sep 11, 2025
Start date
Oct 21, 2025
Primary completion
Jan 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Aug 10, 2026

Study contacts

Angela Zhu, BS
Contact
angela.zhu@hsc.utah.edu
801-662-3675
Michelle Wilcox
Contact
michelle.o.wilcox@hsc.utah.edu
801-581-6410
Jody Lin, MD, MS
principal investigator · University of Utah

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion